Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

Antigen Processing Pathways

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combined Modeling Approaches for Assessing Sodium-Iodide Symporter Inhibition.

Journal of chemical information and modeling·2026

Same author

Leveraging Consensus Docking Approaches for Human Mitochondrial Complexes I and III.

Chemical research in toxicology·2025

Same author

Exploring the Cell Biological and Functional Effects of the First Disease Associated KCC1 Genetic Variant.

Journal of cellular physiology·2025

Same author

Retrospective analysis of clinical laboratory parameters in Han Wistar rat controls.

Frontiers in toxicology·2025

Same author

A Simple Framework for Collaborative Development of Predictive Models Trained on Proprietary Data.

Journal of chemical information and modeling·2025

Same author

Data-driven assessment of bioisosteric replacements and their influence on off-target activity profiles.

RSC medicinal chemistry·2025

Search research articles

Related Experiment Video

Updated: May 23, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Exploring diverse approaches for predicting interferon-gamma release: utilizing MHC class II and peptide sequences.

Abir Omran¹, Alexander Amberg², Gerhard F Ecker¹

¹Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.

Briefings in Bioinformatics

|March 11, 2025

Summary

Predicting therapeutic protein immunogenicity is crucial for drug safety. This study developed a computational model using random forest to accurately forecast interferon-gamma release, improving upon traditional experimental methods.

Keywords:

T-cell response immunology machine learning predictive modeling

More Related Videos

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Related Experiment Videos

Last Updated: May 23, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

Area of Science:

Biotechnology
Immunology
Computational Biology

Background:

Therapeutic proteins require immunogenicity assessment for safety and efficacy.
Current experimental methods for assessing immunogenicity are costly and time-consuming.
Screening diverse peptide sets across Major Histocompatibility Complex (MHC) alleles is challenging.

Purpose of the Study:

To develop a computational classification model for predicting interferon-gamma release.
To utilize peptide sequence and MHC class II (MHC-II) allele pseudo-sequence for prediction.
To enhance the screening of immunogenic peptides for therapeutic proteins.

Main Methods:

Utilized a dataset from the Immune Epitope Database, labeled as active or inactive.
Employed a random forest algorithm with letter-based encoding for classification.
Evaluated model generalizability using a T-cell proliferation dataset.

Main Results:

The random forest model with letter-based encoding demonstrated superior performance in predicting interferon-gamma release.
Feature importance analysis provided insights into model decision-making.
Virtual single-point mutations enhanced model interpretability.

Conclusions:

A computational approach can effectively predict T-cell response to therapeutic proteins.
The developed model offers a more efficient alternative to experimental immunogenicity assays.
Further research can leverage this model for improved drug development and safety assessment.